| Primary |
| Macular Degeneration |
48.1% |
| Choroidal Neovascularisation |
19.6% |
| Polypoidal Choroidal Vasculopathy |
10.7% |
| Age-related Macular Degeneration |
8.7% |
| Myopia |
2.6% |
| Retinal Vascular Disorder |
2.1% |
| Chorioretinopathy |
1.4% |
| Haemangioma |
1.4% |
| Haemangioma Of Retina |
0.8% |
| Retinal Neovascularisation |
0.8% |
| Product Used For Unknown Indication |
0.6% |
| Atrial Fibrillation |
0.5% |
| Chorioretinal Atrophy |
0.5% |
| Drug Use For Unknown Indication |
0.5% |
| Telangiectasia |
0.5% |
| Choroid Melanoma |
0.3% |
| Histoplasmosis |
0.3% |
| Macular Oedema |
0.3% |
| Maculopathy |
0.3% |
| Neovascularisation |
0.3% |
|
| Visual Acuity Reduced |
35.6% |
| Retinal Haemorrhage |
11.7% |
| Vitreous Haemorrhage |
9.7% |
| Retinal Pigment Epithelial Tear |
6.5% |
| Subretinal Fibrosis |
4.5% |
| Choroidal Neovascularisation |
3.2% |
| Myocardial Infarction |
3.2% |
| Retinal Detachment |
2.6% |
| Visual Field Defect |
2.6% |
| Macular Hole |
2.3% |
| Retinal Vascular Disorder |
2.3% |
| Detachment Of Retinal Pigment Epithelium |
1.9% |
| Polypoidal Choroidal Vasculopathy |
1.9% |
| Skin Exfoliation |
1.9% |
| Transient Ischaemic Attack |
1.9% |
| Chorioretinal Atrophy |
1.6% |
| Macular Degeneration |
1.6% |
| Retinal Degeneration |
1.6% |
| Retinal Tear |
1.6% |
| Syncope Vasovagal |
1.6% |
|
| Secondary |
| Macular Degeneration |
31.5% |
| Product Used For Unknown Indication |
24.8% |
| Drug Use For Unknown Indication |
22.4% |
| Age-related Macular Degeneration |
9.9% |
| Myopia |
3.8% |
| Polypoidal Choroidal Vasculopathy |
2.7% |
| Choroidal Neovascularisation |
2.0% |
| Haemangioma |
0.9% |
| Hypertension |
0.6% |
| Transient Ischaemic Attack |
0.4% |
| Photodynamic Therapy |
0.3% |
| Premedication |
0.2% |
| Retinal Vascular Disorder |
0.2% |
| Telangiectasia |
0.2% |
| Atrial Fibrillation |
0.1% |
| Prophylaxis |
0.1% |
| Rash Macular |
0.1% |
|
| Visual Acuity Reduced |
18.9% |
| Chorioretinal Disorder |
15.3% |
| Macular Hole |
7.7% |
| Retinal Pigment Epithelial Tear |
7.7% |
| Retinal Haemorrhage |
7.1% |
| Transient Ischaemic Attack |
6.1% |
| Incontinence |
4.1% |
| Cerebellar Infarction |
3.1% |
| Choroidal Dystrophy |
3.1% |
| Death |
3.1% |
| Myocardial Infarction |
3.1% |
| Cerebrovascular Accident |
2.6% |
| Choroidal Neovascularisation |
2.6% |
| Lacunar Infarction |
2.6% |
| Retinal Degeneration |
2.6% |
| Retinal Ischaemia |
2.6% |
| Syncope |
2.6% |
| Vitreous Haemorrhage |
2.6% |
| Hepatic Enzyme Increased |
1.5% |
| Inappropriate Schedule Of Drug Administration |
1.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
52.9% |
| Drug Use For Unknown Indication |
18.1% |
| Age-related Macular Degeneration |
13.3% |
| Macular Degeneration |
12.8% |
| Prophylaxis |
0.5% |
| Choroidal Neovascularisation |
0.4% |
| Hypertension |
0.4% |
| Angina Pectoris |
0.3% |
| Arrhythmia |
0.3% |
| Infection Prophylaxis |
0.3% |
| Retinal Disorder |
0.3% |
| Gastric Ulcer |
0.1% |
| Glaucoma |
0.1% |
| Hypoaesthesia |
0.1% |
| Neovascularisation |
0.1% |
| Weight Control |
0.1% |
|
| Retinal Pigment Epithelial Tear |
20.0% |
| Vitreous Haemorrhage |
18.7% |
| Retinal Haemorrhage |
15.3% |
| Visual Acuity Reduced |
13.3% |
| Cerebral Infarction |
5.3% |
| Inappropriate Schedule Of Drug Administration |
2.7% |
| Intraocular Pressure Increased |
2.7% |
| Asthenia |
2.0% |
| Cataract |
2.0% |
| Cerebellar Infarction |
2.0% |
| Death |
2.0% |
| Endophthalmitis |
2.0% |
| Myocardial Infarction |
2.0% |
| Vertigo Positional |
2.0% |
| Abdominal Hernia |
1.3% |
| Arthralgia |
1.3% |
| Blindness |
1.3% |
| Cataract Subcapsular |
1.3% |
| Drug Ineffective |
1.3% |
| Glaucoma |
1.3% |
|
